phosphatidylcholines has been researched along with fluconazole in 14 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (fluconazole) | Trials (fluconazole) | Recent Studies (post-2010) (fluconazole) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 9,343 | 721 | 3,664 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | fluconazole (IC50) |
|---|---|---|---|
| Lanosterol 14-alpha demethylase | Candida albicans SC5314 | 0.1296 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 9.21 | |
| Sterol 14-alpha demethylase | Trypanosoma cruzi strain CL Brener | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 11 (78.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrillo-Muñoz, AJ; Cossum, PA; del Valle, O; Miranda, Y; Quindós, G; Ruesga, MT; Tur, C; Wallace, TL | 1 |
| Schiller, GJ; Winston, DJ | 1 |
| Blowey, DL; Garg, UC; Kearns, GL; Warady, BA | 1 |
| Ellis, RW; Fisher, NC; Hastings, JG; Jones, SG; Miller, SJ; Mutimer, DJ; Singhal, S | 1 |
| Denning, DW; Moore, CB; Morrissey, J; Warn, PA | 1 |
| Demir, M; Kaldir, M; Turgut, B; Vural, O | 1 |
| Avorn, J; Fischer, MA; Rubin, RH; Winkelmayer, WC | 1 |
| Leather, H; Wingard, JR | 1 |
| Addison, RM; Alexander, BD; Alspaugh, JA; Chao, NJ; Dodds Ashley, ES; Perfect, JR | 1 |
| Harada, AS; Lau, W | 1 |
| Beltrame, A; Cerana, M; De Maria, A; Di Biagio, A; Pacini, D | 1 |
| Capilla, J; Clemons, KV; Sobel, RA; Stevens, DA | 1 |
| Abe, F; Hiraki, T; Usui, K | 1 |
| Calucci, L; Castellano, S; Cicogna, F; Forte, C; Pinzino, C; Porta, A | 1 |
1 trial(s) available for phosphatidylcholines and fluconazole
| Article | Year |
|---|---|
Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aerosols; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Safety; Transplantation, Homologous; Treatment Outcome | 2006 |
13 other study(ies) available for phosphatidylcholines and fluconazole
| Article | Year |
|---|---|
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Deoxycholic Acid; Drug Carriers; Drug Combinations; Fluconazole; Humans; Itraconazole; Liposomes; Microbial Sensitivity Tests; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
Topics: Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Combinations; Fluconazole; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Randomized Controlled Trials as Topic | 2000 |
Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis.
Topics: Amphotericin B; Antifungal Agents; Ascitic Fluid; Candidiasis; Drug Combinations; Drug Therapy, Combination; Fluconazole; Humans; Infant; Infusions, Intravenous; Male; Peritoneal Dialysis; Peritonitis; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida; Candida albicans; Drug Combinations; Drug Resistance, Microbial; Female; Fluconazole; Humans; Liver Transplantation; Male; Medical Audit; Microbial Sensitivity Tests; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Care; Postoperative Complications; Prospective Studies | 2000 |
In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Combinations; Drug Resistance, Microbial; Fluconazole; Immunocompromised Host; Male; Mice; Microbial Sensitivity Tests; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B.
Topics: Amphotericin B; Arthritis, Infectious; Blast Crisis; Candidiasis; Drug Combinations; Drug Resistance; Fatal Outcome; Female; Fluconazole; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Case-Control Studies; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Hepatotoxicity associated with antifungal therapy after bone marrow transplantation.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Combinations; Echinocandins; Female; Fluconazole; Fungemia; Humans; Ileostomy; Lipopeptides; Middle Aged; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Practice Guidelines as Topic | 2007 |
Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Arteritis; Body Temperature; Brain; Cisterna Magna; Coccidioides; Drug Combinations; Fluconazole; Granuloma; Injections, Intravenous; Male; Meningitis, Fungal; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Spinal Cord; Survival Analysis | 2007 |
Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae.
Topics: Antifungal Agents; Cell Membrane Permeability; Drug Resistance, Fungal; Fluconazole; Fluorescence Polarization; Gene Deletion; Membrane Fluidity; Oxidoreductases; Phosphatidylcholines; Saccharomyces cerevisiae; Water | 2009 |
Interaction of azole compounds with DOPC and DOPC/ergosterol bilayers by spin probe EPR spectroscopy: implications for antifungal activity.
Topics: Antifungal Agents; Azoles; Candida albicans; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Ergosterol; Fluconazole; Lipid Bilayers; Phosphatidylcholines; Spin Labels; Temperature | 2013 |